Krebs Biochem Standalone June 2025 Net Sales at Rs 5.48 crore, down 57.48% Y-o-Y
Broker Research
August 22, 2025 / 10:45 IST
Reported Standalone quarterly numbers for Krebs Biochemicals & Industries are: Net Sales at Rs 5.48 crore in June 2025 down 57.48% from Rs. 12.89 crore in June 2024. Quarterly Net Loss at Rs. 5.32 crore in June 2025 down 2.96% from Rs. 5.17 crore in June 2024. EBITDA stands negative at Rs. 2.07 crore in June 2025 up 4.17% from Rs. 2.16 crore in June 2024. Krebs Biochem shares closed at 74.56 on August 20, 2025 (NSE) and has given -12.31% returns over the last 6 months and -12.56% over the last 12 months.
| Krebs Biochemicals & Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
Story continues below Advertisement
| Jun'25 | Mar'25 | Jun'24 | | Net Sales/Income from operations | 5.48 | 6.10 | 12.89 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 5.48 | 6.10 | 12.89 | | EXPENDITURE | | Consumption of Raw Materials | 0.04 | -0.10 | 0.37 | | Purchase of Traded Goods | -- | -- | 0.04 | | Increase/Decrease in Stocks | 0.25 | 0.67 | 0.85 | | Power & Fuel | -- | -- | -- | | Employees Cost | 2.75 | 3.45 | 4.25 | | Depreciation | 1.60 | 1.57 | 1.69 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 4.53 | 7.49 | 9.58 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -3.69 | -6.98 | -3.89 | | Other Income | 0.01 | 0.34 | 0.03 | | P/L Before Int., Excpt. Items & Tax | -3.67 | -6.64 | -3.85 | | Interest | 1.65 | 1.61 | 1.32 | | P/L Before Exceptional Items & Tax | -5.32 | -8.25 | -5.17 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.32 | -8.25 | -5.17 | | Tax | -- | 0.02 | -- | | P/L After Tax from Ordinary Activities | -5.32 | -8.27 | -5.17 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.32 | -8.27 | -5.17 | | Equity Share Capital | 21.56 | 21.56 | 21.56 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.47 | -3.83 | -2.40 | | Diluted EPS | -2.47 | -3.83 | -2.40 | | EPS After Extra Ordinary | | Basic EPS | -2.47 | -3.83 | -2.40 | | Diluted EPS | -2.47 | -3.83 | -2.40 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
